Understanding Peptide Purity: What COAs, HPLC Testing, and Mass Spectrometry Tell You

When discussing research peptides, most of the conversation focuses on dosing, timing, and protocol design. But none of those variables matter if the compound in the vial is not what the label says it is, or if it contains significant impurities. Peptide purity refers to the percentage of the total material that is the intended peptide sequence versus impurities — which can include truncated sequences (incomplete peptides), deletion sequences (peptides missing one or more amino acids), oxidized forms, aggregated forms, residual solvents from manufacturing, and in the worst cases, completely different compounds or contaminants. A peptide listed as 98% purity means that 98% of the material is the correct, full-length peptide and 2% is some combination of impurities. The difference between 98% and 85% purity is not trivial — at 85%, one in seven molecules is not what you think it is, which affects dosing accuracy, can introduce unpredictable effects from the impurities, and raises questions about the manufacturing process that produced such a low yield. The unregulated nature of the research peptide market makes purity verification especially important. There is no FDA oversight of research-grade peptides, and the barrier to entry for suppliers is low. The Certificate of Analysis (COA) is the primary quality document — and knowing how to read one is an essential skill.

A Certificate of Analysis is a document issued by the manufacturer or a third-party testing laboratory that reports the results of quality testing performed on a specific batch of product. A legitimate COA should include: the peptide name and sequence, the lot or batch number (which should match the label on your vial), the date of testing, the testing laboratory name, and the results of specific analytical tests — typically HPLC purity, mass spectrometry identity confirmation, and sometimes endotoxin testing, sterility testing, and residual solvent analysis. The COA should be batch-specific. If a supplier provides the same COA for every order regardless of batch number, that is a red flag — it suggests the document is generic rather than reflecting actual testing of the product you received. Similarly, a COA without a testing laboratory name, without a batch number, or with results that seem identical across different peptides and batches should be viewed skeptically. Reputable suppliers provide batch-specific COAs automatically with each order and often use independent third-party laboratories for testing rather than relying solely on in-house quality control. Third-party testing is more credible because the testing lab has no financial incentive to produce favorable results.

High-Performance Liquid Chromatography (HPLC) is the standard analytical method for determining peptide purity. Here is how it works in simplified terms: the peptide sample is dissolved and injected into a column packed with a stationary phase (typically a C18 reversed-phase column). A liquid mobile phase (a mixture of water and organic solvent like acetonitrile) flows through the column at high pressure. Different components of the sample interact differently with the column material and the mobile phase, causing them to travel through the column at different speeds. As each component exits the column, a UV detector measures its absorbance at a specific wavelength (typically 220 nm for peptides), producing a chromatogram — a graph with time on the x-axis and detector response (essentially, the amount of material) on the y-axis. Each peak on the chromatogram represents a different component in the sample. The main peak is (ideally) your target peptide. Smaller peaks represent impurities. Purity is calculated as the area of the main peak divided by the total area of all peaks, expressed as a percentage. A purity of 98% HPLC means the main peak represents 98% of the total peak area. When reading a COA, look for: the purity percentage (95%+ is generally considered acceptable for research; 98%+ is high purity), the chromatogram image (a clean chromatogram with a single dominant peak and minimal noise), the column type and mobile phase conditions (these affect the analysis quality), and whether the testing was performed by a named, identifiable laboratory.

While HPLC tells you how pure the sample is, mass spectrometry (MS) tells you what the sample actually is. Mass spectrometry measures the molecular weight of the compound, which serves as an identity fingerprint. Every peptide has a known theoretical molecular weight based on its amino acid sequence. If the mass spectrometry result matches the theoretical molecular weight (within an acceptable tolerance, typically ±1 Da), this confirms that the main component of the sample is indeed the intended peptide. The most common MS methods for peptide analysis are MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization - Time of Flight) and ESI-MS (Electrospray Ionization Mass Spectrometry). On a COA, the MS result is typically reported as the observed molecular weight alongside the theoretical molecular weight. For example, a COA for BPC-157 might report: 'Theoretical MW: 1419.53 Da. Observed MW: 1419.56 Da.' The close match confirms identity. A COA that reports HPLC purity of 99% but does not include mass spectrometry data is incomplete — it tells you the sample is pure but not what it is pure of. Both tests together provide a complete quality picture: HPLC confirms purity, and MS confirms identity.

Not all COAs are created equal, and the unregulated nature of the research peptide market means that fabricated or misleading COAs exist. Here are red flags to watch for: No batch number or a batch number that does not match your product label. No laboratory name or a laboratory that cannot be independently verified (search for the lab's website, address, and accreditations). Identical results across multiple different peptides or batches — if the HPLC purity is reported as exactly 99.2% on every single product, the data is likely generic. No chromatogram image — a legitimate HPLC analysis produces a chromatogram, and a real COA should include it. Purity reported to unrealistic precision (e.g., 99.97%) — HPLC has inherent variability, and reporting to hundredths of a percent suggests the number was fabricated rather than measured. MS data that shows the wrong molecular weight or does not correspond to the peptide's known sequence. COAs dated far in the past — if the testing date is years before your purchase, the COA may not reflect the current batch. The single most reliable way to verify peptide quality is to send a sample to an independent third-party laboratory for your own testing. Several laboratories offer peptide analysis services for $50-$150 per sample. This is not practical for every purchase but is valuable for verifying a new supplier.

Understanding purity affects your protocol in concrete ways. First, dosing accuracy depends on purity. If a vial is labeled as containing 5 mg of a peptide but the actual purity is 85%, you effectively have 4.25 mg of active compound plus 0.75 mg of impurities. Your calculated dose based on 5 mg will be roughly 15% lower than intended. For research where precise dosing matters, purity must be factored into calculations. Second, batch consistency affects protocol reproducibility. If you switch suppliers or receive a different batch, variations in purity can change the effective dose even if the nominal dose stays the same. Logging the batch number and purity alongside your protocol data in Dosed allows you to identify whether changes in response correlate with changes in batch or supplier. Third, storage conditions affect purity over time. Peptides can degrade through oxidation, aggregation, and hydrolysis, especially when reconstituted. Purity at the time of manufacture is not the same as purity after the vial has been reconstituted, stored at room temperature, and drawn from repeatedly over weeks. Proper storage (refrigerated for reconstituted peptides, frozen for unreconstituted lyophilized peptides) preserves purity and extends usable life. Dosed can track reconstitution dates, storage conditions, and batch information alongside your protocol logs, creating a complete record that helps you maintain consistency and identify quality issues. This content is for educational and informational purposes only. It is not medical advice. Always consult a qualified healthcare professional before starting any protocol.